![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Sentigen Holding Reports Sale of Specialty Media Division
Sentigen Holding Reports Sale of Specialty Media Division
Sentigen Holding has sold the Specialty Media Division of its wholly owned subsidiary, Cell & Molecular Technologies to Chemicon International, a wholly owned subsidiary of Serologicals Corporation. Under the terms of the agreement, Serologicals agreed to pay Sentigen Holding $6.5 million in cash, subject to certain post-closing adjustments and escrow, for the assets of the division. In addition to the purchase price Serologicals has retired the mortgage note with a balance of $243,310 on the division's facility at 580 Marshall Street, Phillipsburg, N.J. 08865.
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct